News Releases
Sep 10 2007
Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
Sep 7 2007
Peregrine Reports Data Showing Bavituximab's Potential to Shrink Prostate Tumors
Sep 4 2007
Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer
Sep 4 2007
Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
Aug 7 2007
Peregrine's Bavituximab HCV Phase Ib Study Results Selected for Oral Presentation at Upcoming AASLD Annual Meeting
Aug 2 2007
Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Jul 26 2007
Peregrine Pharmaceuticals Adds Pharmaceutical Executive as Head of Business Development for Asia and Europe
Jul 25 2007
Peregrine Receives Deficiency Notice From Nasdaq Regarding Minimum Bid Price Rule
Jul 23 2007
Peregrine Enters Contract Negotiations With U.S. DTRA for Hemorrhagic Fevers
Jul 11 2007
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2007